Did You Know?

Editor’s Picks

Latest News

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial

SOUTH SAN FRANCISCO, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...

PervasID to Present Solution for Tracking Medical Equipment and Surgical Instruments at Electronic and Biomedical Engineering Expo 2022

Company to exhibit and deliver presentation on solution which enhances decontamination, increases sterilisation processes, ensures mission-critical medical devices are available...

Zillion’s Restore Coach Institute is Now an Approved Health and Wellness Coach Training and Education Program by the National Board of Health and Wellness Coaching (NBHWC)

The employee health and wellness leader’s coaching graduates are now eligible to apply for the HWC Certifying Examination to become...

Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers

WAKEFIELD, MA / ACCESSWIRE / June 23, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today...

error: Content is protected !!